Abstract:Cholera caused by Vibrio cholerae O139 could reemerge, and proactive development of an effective O139 vaccine would be prudent. To define immunoreactive and potentially immunogenic carbohydrate targets of Vibrio cholerae O139, we assessed immunoreactivities of various O-specific polysaccharide (OSP)-related saccharides with plasma from humans hospitalized with cholera caused by O139, comparing responses to those induced in recipients of a commercial oral whole-cell killed bivalent (O1 and O139) cholera vaccine (WC-O1/O139). We also assessed conjugate vaccines containing selected subsets of these saccharides for their ability to induce protective immunity using a mouse model of cholera. We found that patients with wild-type O139 cholera develop IgM, IgA, and IgG immune responses against O139 OSP and many of its fragments, but we were able to detect only a moderate IgM response to purified O139 OSP-core, and none to its fragments, in immunologically naive recipients of WC-O1/O139. We found that immunoreactivity of O139-specific polysaccharides with antibodies elicited by wild-type infection markedly increase when saccharides contain colitose and phosphate residues, that a synthetic terminal tetrasaccharide fragment of OSP is more immunoreactive and protectively immunogenic than complete OSP, that native OSP-core is a better protective immunogen than the synthetic OSP lacking core, and that functional vibriocidal activity of antibodies predicts in vivo protection in our model but depends on capsule thickness. Our results suggest that O139 OSP-specific responses are not prominent following vaccination with a currently available oral cholera vaccine in immunologically naive humans and that vaccines targeting V. cholerae O139 should be based on native OSP-core or terminal tetrasaccharide. IMPORTANCE Cholera is a severe dehydrating illness of humans caused by Vibrio cholerae serogroup O1 or O139. Protection against cholera is serogroup specific, and Citation Kamruzzaman M, Kelly M, Charles RC, Harris JB, Calderwood SB, Akter A, Biswas R, Kaisar MH, Bhuiyan TR, Ivers LC, Ternier R, Jerome J-G, Pfister HB, Lu X, Soliman SE, Ruttens B, Saksena R, Me cárová J, Cížová A, Qadri F, Bystrický S, Ková c P, Xu P, Ryan ET. 2021. Defining polysaccharide-specific antibody targets against Vibrio cholerae O139 in humans following O139 cholera and following vaccination with a commercial bivalent oral cholera vaccine, and evaluation of conjugate vaccines targeting O139. mSphere 6: e00114-21. https://doi.org/10.1128/mSphere .00114-21. Editor David W. Pascual, University of Florida Copyright © 2021 Kamruzzaman et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license. Address correspondence to Mohammad Kamruzzaman, mohammad.zaman@icddrb.org. Received 4 February 2021 Accepted 2 June 2021 Published 7 July 2021 July/August 2021 Volume 6 Issue 4 e00114-21 msphere.asm.org 1 RESEARCH ARTICLE

Investigation of the Roles of Toxin-Coregulated Pili and Mannose-Sensitive Hemagglutinin Pili in the Pathogenesis of Vibrio cholerae O139 Infection

The role of toxin-coregulated pili in the pathogenesis of Vibrio cholerae O1 El Tor

Pathogenic Potential of Environmental Vibrio cholerae Strains Carrying Genetic Variants of the Toxin-Coregulated Pilus Pathogenicity Island

Toxin, toxin-coregulated pili, and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans.

Redox Pathway Sensing Bile Salts Activates Virulence Gene Expression in Vibrio Cholerae

Vibrio Pathogenicity Island and Cholera Toxin Genetic Element-Associated Virulence Genes and Their Expression in Non-O1 Non-O139 Strains of Vibrio cholerae

Inactivated Vibrio cholerae Strains That Express TcpA via the toxT-139F Allele Induce Antibody Responses against TcpA

Transcriptional profiling of Vibrio cholerae O1 following exposure to human anti- lipopolysaccharide monoclonal antibodies

An essential host dietary fatty acid promotes TcpH inhibition of TcpP proteolysis promoting virulence gene expression in Vibrio cholerae

Antagonism toward the intestinal microbiota and its effect on Vibrio cholerae virulence

Comparative Genomic Analyses of the Vibrio Pathogenicity Island and Cholera Toxin Prophage Regions in Nonepidemic Serogroup Strains of Vibrio cholerae

Quorum sensing and a global regulator TsrA control expression of type VI secretion and virulence in Vibrio cholerae

Production of putative enhanced oral cholera vaccine strains that express toxin-coregulated pilus

Virulence Regulation and Innate Host Response in the Pathogenicity of Vibrio cholerae

Characterization of VPI Pathogenicity Island and CTXφ Prophage in Environmental Strains of Vibrio cholerae

Defining Polysaccharide-Specific Antibody Targets against <named-content content-type='genus-species'>Vibrio cholerae</named-content> O139 in Humans following O139 Cholera and following Vaccination with a Commercial Bivalent Oral Cholera Vaccine, and Evaluation of Conjugate Vaccines Targeting O139

Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers

Intracellular Expression of CTB in Vibrio cholerae Strains in Laboratory Culture Conditions

In vivo evaluation of pathogenicity of clinical and environmental isolates of Vibrio cholerae

Emergence of a New Cholera Pandemic: Molecular Analysis of Virulence Determinants in Vibrio cholerae 0139 and Development of a Live Vaccine Prototype

Immunizing Adult Female Mice with a TcpA-A2-CTB Chimera Provides a High Level of Protection for Their Pups in the Infant Mouse Model of Cholera